• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

RNA N6-甲基腺苷甲基化的表观遗传调控在糖脂代谢中的作用。

The Epigenetic Regulation of RNA N6-Methyladenosine Methylation in Glycolipid Metabolism.

机构信息

Guangdong Provincial Key Laboratory of Medical Molecular Diagnostics, Institute of Aging Research, School of Medical Technology, Guangdong Medical University, Songshan Lake, Dongguan 523808, China.

出版信息

Biomolecules. 2023 Feb 1;13(2):273. doi: 10.3390/biom13020273.

DOI:10.3390/biom13020273
PMID:36830642
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9953413/
Abstract

The highly conserved and dynamically reversible N6-methyladenine (m6A) modification has emerged as a critical gene expression regulator by affecting RNA splicing, translation efficiency, and stability at the post-transcriptional level, which has been established to be involved in various physiological and pathological processes, including glycolipid metabolism and the development of glycolipid metabolic disease (GLMD). Hence, accumulating studies have focused on the effects and regulatory mechanisms of m6A modification on glucose metabolism, lipid metabolism, and GLMD. This review summarizes the underlying mechanism of how m6A modification regulates glucose and lipid metabolism-related enzymes, transcription factors, and signaling pathways and the advances of m6A regulatory mechanisms in GLMD in order to deepen the understanding of the association of m6A modification with glycolipid metabolism and GLMD.

摘要

高度保守且动态可逆的 N6-甲基腺嘌呤(m6A)修饰已成为一种关键的基因表达调控因子,通过影响 RNA 剪接、翻译效率和转录后水平的稳定性,参与了各种生理和病理过程,包括糖脂代谢和糖脂代谢疾病(GLMD)的发生。因此,越来越多的研究集中在 m6A 修饰对葡萄糖代谢、脂代谢和 GLMD 的影响及其调控机制上。本综述总结了 m6A 修饰调节葡萄糖和脂质代谢相关酶、转录因子和信号通路的潜在机制,以及 m6A 调控机制在 GLMD 中的研究进展,以期加深对 m6A 修饰与糖脂代谢和 GLMD 关联的理解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a22/9953413/040f933ae1b8/biomolecules-13-00273-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a22/9953413/a5c5d4285e41/biomolecules-13-00273-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a22/9953413/c299e5c51806/biomolecules-13-00273-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a22/9953413/040f933ae1b8/biomolecules-13-00273-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a22/9953413/a5c5d4285e41/biomolecules-13-00273-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a22/9953413/c299e5c51806/biomolecules-13-00273-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a22/9953413/040f933ae1b8/biomolecules-13-00273-g003.jpg

相似文献

1
The Epigenetic Regulation of RNA N6-Methyladenosine Methylation in Glycolipid Metabolism.RNA N6-甲基腺苷甲基化的表观遗传调控在糖脂代谢中的作用。
Biomolecules. 2023 Feb 1;13(2):273. doi: 10.3390/biom13020273.
2
Epigenetic role of N6-methyladenosine (m6A) RNA methylation in the cardiovascular system.N6-甲基腺苷(m6A)RNA 甲基化在心血管系统中的表观遗传作用。
J Zhejiang Univ Sci B. 2020 Jul;21(7):509-523. doi: 10.1631/jzus.B1900680.
3
N6-methyladenosine RNA modification: A promising regulator in central nervous system injury.N6-甲基腺苷RNA修饰:中枢神经系统损伤中一个有前景的调节因子。
Exp Neurol. 2021 Nov;345:113829. doi: 10.1016/j.expneurol.2021.113829. Epub 2021 Jul 31.
4
Transcriptome-wide analysis of N6-methyladenosine uncovers its regulatory role in gene expression in the lepidopteran Bombyx mori.转录组范围内分析 N6-甲基腺苷揭示了其在鳞翅目昆虫家蚕基因表达中的调控作用。
Insect Mol Biol. 2019 Oct;28(5):703-715. doi: 10.1111/imb.12584. Epub 2019 Apr 29.
5
N6-methyladenosine RNA methylation in diabetic kidney disease.N6-甲基腺苷 RNA 甲基化在糖尿病肾病中的作用。
Biomed Pharmacother. 2024 Feb;171:116185. doi: 10.1016/j.biopha.2024.116185. Epub 2024 Jan 18.
6
Reversible N6-methyladenosine of RNA: The regulatory mechanisms on gene expression and implications in physiology and pathology.RNA的可逆N6-甲基腺苷:基因表达调控机制及其在生理和病理中的意义
Genes Dis. 2020 Jul 6;7(4):585-597. doi: 10.1016/j.gendis.2020.06.011. eCollection 2020 Dec.
7
Epigenetic regulation of N6-methyladenosine modifications in obesity.肥胖中 N6-甲基腺苷修饰的表观遗传调控。
J Diabetes Investig. 2021 Aug;12(8):1306-1315. doi: 10.1111/jdi.13571. Epub 2021 Jun 3.
8
N6-methyladenosine modification and metabolic reprogramming of digestive system malignancies.N6-甲基腺苷修饰与消化系统恶性肿瘤的代谢重编程。
Cancer Lett. 2022 Sep 28;544:215815. doi: 10.1016/j.canlet.2022.215815. Epub 2022 Jul 5.
9
The role of N6-methyladenosine (m6A) in eye diseases.N6-甲基腺苷(m6A)在眼病中的作用。
Mol Biol Rep. 2021 Aug;48(8):6145-6150. doi: 10.1007/s11033-021-06596-3. Epub 2021 Jul 31.
10
Mechanism of RNA modification N6-methyladenosine in human cancer.RNA 修饰 N6-甲基腺苷在人类癌症中的作用机制。
Mol Cancer. 2020 Jun 8;19(1):104. doi: 10.1186/s12943-020-01216-3.

引用本文的文献

1
Alternative Splicing Regulation in Metabolic Disorders.代谢紊乱中的可变剪接调控
Obes Rev. 2025 May 27:e13950. doi: 10.1111/obr.13950.
2
YTHDF1 gene inhibits epilepsy progression by epigenetic activation of PTEN gene.YTHDF1基因通过对PTEN基因进行表观遗传激活来抑制癫痫进展。
Heliyon. 2024 Oct 17;10(20):e39481. doi: 10.1016/j.heliyon.2024.e39481. eCollection 2024 Oct 30.
3
Unraveling the genetic and epigenetic landscape governing intramuscular fat deposition in rabbits: Insights and implications.解析调控家兔肌内脂肪沉积的遗传和表观遗传图谱:见解与启示

本文引用的文献

1
LncRNA Airn alleviates diabetic cardiac fibrosis by inhibiting activation of cardiac fibroblasts via a m6A-IMP2-p53 axis.长链非编码 RNA Airn 通过 m6A-IMP2-p53 轴抑制心肌成纤维细胞的激活,从而减轻糖尿病性心脏纤维化。
Biol Direct. 2022 Nov 16;17(1):32. doi: 10.1186/s13062-022-00346-6.
2
LINC01468 drives NAFLD-HCC progression through CUL4A-linked degradation of SHIP2.LINC01468通过与CUL4A相关的SHIP2降解驱动非酒精性脂肪性肝病-肝癌进展。
Cell Death Discov. 2022 Nov 7;8(1):449. doi: 10.1038/s41420-022-01234-8.
3
PARP1 Is Upregulated by Hyperglycemia Via N6-methyladenosine Modification and Promotes Diabetic Retinopathy.
Food Chem (Oxf). 2024 Aug 30;9:100222. doi: 10.1016/j.fochms.2024.100222. eCollection 2024 Dec 30.
4
METTL3 shapes m6A epitranscriptomic landscape for successful human placentation.METTL3塑造了用于成功人类胎盘形成的m6A表观转录组格局。
bioRxiv. 2024 Jul 13:2024.07.12.603294. doi: 10.1101/2024.07.12.603294.
PARP1 通过 N6-甲基腺苷修饰被高血糖上调,并促进糖尿病视网膜病变。
Discov Med. 2022 Sep-Oct;34(172):115-129.
4
Exploration of N6-Methyladenosine Profiles of mRNAs and the Function of METTL3 in Atherosclerosis.mRNA 中 N6-甲基腺苷的特征分析及 METTL3 在动脉粥样硬化中的功能研究。
Cells. 2022 Sep 24;11(19):2980. doi: 10.3390/cells11192980.
5
mA transferase METTL3 regulates endothelial-mesenchymal transition in diabetic retinopathy via lncRNA SNHG7/KHSRP/MKL1 axis.甲基转移酶METTL3通过lncRNA SNHG7/KHSRP/MKL1轴调节糖尿病视网膜病变中的内皮-间充质转化。
Genomics. 2022 Nov;114(6):110498. doi: 10.1016/j.ygeno.2022.110498. Epub 2022 Sep 26.
6
FTO promotes liver inflammation by suppressing m6A mRNA methylation of IL-17RA.FTO 通过抑制 IL-17RA 的 m6A mRNA 甲基化来促进肝脏炎症。
Front Oncol. 2022 Sep 12;12:989353. doi: 10.3389/fonc.2022.989353. eCollection 2022.
7
Long non-coding RNA NEAT1 mediated RPRD1B stability facilitates fatty acid metabolism and lymph node metastasis via c-Jun/c-Fos/SREBP1 axis in gastric cancer.长链非编码 RNA NEAT1 通过 c-Jun/c-Fos/SREBP1 轴介导 RPRD1B 稳定性促进胃癌中的脂肪酸代谢和淋巴结转移。
J Exp Clin Cancer Res. 2022 Sep 29;41(1):287. doi: 10.1186/s13046-022-02449-4.
8
mA-induced lncDBET promotes the malignant progression of bladder cancer through FABP5-mediated lipid metabolism.mA 诱导的 lncDBET 通过 FABP5 介导的脂质代谢促进膀胱癌的恶性进展。
Theranostics. 2022 Aug 29;12(14):6291-6307. doi: 10.7150/thno.71456. eCollection 2022.
9
N6-methyladenosine modification of circ_0003215 suppresses the pentose phosphate pathway and malignancy of colorectal cancer through the miR-663b/DLG4/G6PD axis.N6-甲基腺苷修饰 circ_0003215 通过 miR-663b/DLG4/G6PD 轴抑制结直肠癌细胞的戊糖磷酸途径和恶性表型。
Cell Death Dis. 2022 Sep 20;13(9):804. doi: 10.1038/s41419-022-05245-2.
10
New roles of N6-methyladenosine methylation system regulating the occurrence of non-alcoholic fatty liver disease with N6-methyladenosine-modified MYC.N6-甲基腺苷甲基化系统通过N6-甲基腺苷修饰的MYC调控非酒精性脂肪性肝病发生的新作用
Front Pharmacol. 2022 Aug 31;13:973116. doi: 10.3389/fphar.2022.973116. eCollection 2022.